Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients

NCT05284032 is registered in ClinicalTrials.gov with Firas El Chaer, MD as lead sponsor.

NCT NCT05284032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05284032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients
Lead sponsor
Firas El Chaer, MD
Phase
Phase 1
Overall status
Terminated
Start date
November 29, 2022
Completion date
June 11, 2024
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, platelet refractoriness